Sanofi (FRA:SNW2)

Market Cap	100.24B
Revenue (ttm)	45.93B
Net Income (ttm)	9.11B
Shares Out	n/a
EPS (ttm)	7.39
PE Ratio	11.00
Forward PE	10.07
Dividend	1.42 (3.49%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	n/a
Open	40.60
Previous Close	40.60
Day's Range	40.60 - 40.60
52-Week Range	38.40 - 54.50
Beta	n/a
RSI	37.61
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SNW2

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.